AKT1 and cancer: Moreover, mutated PTEN can cause the activation of the AKT signaling pathway, and subsequently regulate the multiple downstream AKT substrates, including FOXO and mTOR 44-46, which are usually downregulated in different types of cancers, including GBMs 47.